Acusphere to Host Conference Call to Discuss Q4 2007 Results.WATERTOWN, Mass. -- Acusphere, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : ACUS acus (a´kus) a needle or needle-like process. acus a needle or needle-like process. ) announced today that it expects to host a conference call on Monday, March 17, 2008, at 8:30 AM ET to discuss the Company's financial results and operational highlights for the fourth quarter of 2007, along with a business outlook for 2008. The call will feature representatives of the Company including Sherri Oberg, President and Chief Executive Officer, Lawrence Gyenes, Senior Vice President and Chief Financial Officer and Dennis Bucceri, Senior Vice President of Regulatory Affairs Regulatory Affairs (RA), also called Government Affairs, is a profession within regulated industries, such as pharmaceuticals, medical devices, energy, and banking. Regulatory Affairs professionals usually have responsibility for the following general areas: To listen to this conference call via audio webcast, please visit the Investor Relations Investor relations The process by which the corporation communicates with its investors. section of the Company's website (www.acusphere.com) at least ten minutes prior to the start of the call and follow the directions there. The webcast will also be available as a replay, starting approximately one hour after the call is finished. Alternately, to access the call via live telephone, please dial 1-888-679-8035, using confirmation code 83030206. Internationally, the call may be accessed by dialing 1-617-213-4848, using the same confirmation code. In addition to the webcast replay, a telephone replay will be available from approximately 10:30 am ET on March 17, 2008 through April 17, 2008. To access the replay, please call 1-888-286-8010 and use the confirmation code of 48980885. The replay is also available internationally at 1-617-801-6888 using the same confirmation code, 48980885. About Acusphere, Inc. Acusphere is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary microsphere Not to be confused with Glass microphere. This article largely refers to micropheres or protein protocells as small spherical units postulated by some scientists as a key stage in the origin of life. technology. We are focused on developing proprietary drugs that can offer significant benefits such as improved safety and efficacy, increased patient compliance, greater ease of use, expanded indications or reduced cost. Our lead product candidate, Imagify(TM) (perflubutane polymer microspheres) injectable in·ject·a·ble adj. Capable of being injected. Used of a drug. n. A drug or medicine that can be injected. suspension, is a cardiovascular drug for the detection of coronary artery disease coronary artery disease, condition that results when the coronary arteries are narrowed or occluded, most commonly by atherosclerotic deposits of fibrous and fatty tissue. , the leading cause of death in the United States. We are currently working towards submitting an NDA (Non Disclosure Agreement) An agreement signed between two parties that have to disclose confidential information to each other in order to do business. In general, the NDA states why the information is being divulged and stipulates that it cannot be used for any (New Drug Application) for Imagify. Imagify is designed to enable ultrasound to compete more effectively with nuclear stress testing Determining the durability of a system by pushing it to its limits. Stress testing a network is performed by transmitting excessive numbers of packets or attempting to break in illegally. , the leading procedure for detecting coronary artery disease. It is estimated that over 10 million procedures are done each year in the U.S. to detect coronary artery disease, the leading cause of death in the United States. Imagify and the Company's other product candidates were created using proprietary technology that enables Acusphere to control the porosity and size of nanoparticles and microspheres in a versatile manner that allows them to be customized to address the delivery needs of a variety of drugs. For more information about Acusphere visit the Company's web site at www.acusphere.com. "Acusphere" and "Imagify" are trademarks of Acusphere, Inc. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion